bioAffinity Technologies, Inc.
BIAF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,038 | $12,860 | $7,198 | $61,237 |
| - Cash | $1,105 | $2,822 | $11,414 | $1,361 |
| + Debt | $1,501 | $1,579 | $252 | $11,364 |
| Enterprise Value | $11,434 | $11,617 | -$3,964 | $71,241 |
| Revenue | $9,362 | $2,532 | $5 | $0 |
| % Growth | 269.7% | 52,617.1% | – | – |
| Gross Profit | $3,379 | $792 | $4 | -$5 |
| % Margin | 36.1% | 31.3% | 90.3% | – |
| EBITDA | -$8,330 | -$7,629 | -$5,609 | -$5,318 |
| % Margin | -89% | -301.3% | -116,777.7% | – |
| Net Income | -$9,040 | -$7,937 | -$8,154 | -$6,326 |
| % Margin | -96.6% | -313.5% | -169,771.2% | – |
| EPS Diluted | -22.5 | -27.3 | -54.3 | -25.8 |
| % Growth | 17.6% | 49.7% | -110.5% | – |
| Operating Cash Flow | -$7,265 | -$6,038 | -$4,071 | -$2,049 |
| Capital Expenditures | -$79 | -$23 | -$220 | $0 |
| Free Cash Flow | -$7,344 | -$6,061 | -$4,291 | -$2,049 |